Patients should avoid buying retatrutide online or copying dosing advice from forums
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
Safer, Evidence-Based Alternatives Available Through the NHS NICE-recommended semaglutide (Wegovy) and MHRA-authorised tirzepatide (Mounjaro) are regulated, evidence-based options for weight management available through NHS specialist services
10.1016/S0140-6736(17)31071-1 57 MllerT
This perspective has shifted substantially over the past 2 decades as accumulating evidence has demonstrated that both tissues secrete bioactive peptides that function as hormones, influencing glucose metabolism, energy expenditure, reproductive physiology, and aspects of aging
5-12 The most common patient-reported adverse effects (AEs) associated with GLP-1 RAs and dual GIP/GLP-1 RAs are gastrointestinal (GI) in nature and may include abdominal pain, constipation, diarrhea, nausea, and vomiting